EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: FINAL RESULTS FROM THE PHASE 3 U-ACHIEVE MAINTENANCE STUDY

Severine Vermeire  ¹     Silvio Danese  ²     Wen Zhou  ³     Xuan Yao  ³     Dapo Ilo  ³     G Levy  ³     Xavier Hebuterne  ⁴     James O. Lindsay  ⁵     Yuri Sanchez Gonzalez  ⁵     Peter D.R. Higgins  ⁶     Jean-Frédéric Colombel  ⁷     Remo Panaccione  ^8    
1 University Hospital Leuven, Leuven, Belgium
² IRCCS, Milan, Italy
³ AbbVie Inc., North Chicago, United States
⁴ CHU de Nice, Université Côte d’Azur, Nice, France
⁵ The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom
⁶ University of Michigan, Ann Arbor, United States
⁷ Icahn School of Medicine at Mount Sinai, New York, United States
⁸ University of Calgary, Calgary, Canada

Topic
IBD, Nurses

Session
Opening Session Part I

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)